title: Prevalence of incidental prostate cancer: A systematic review of autopsy studies.
abstract: Prostate cancer screening may detect nonprogressive cancers, leading to overdiagnosis and overtreatment. The potential for overdiagnosis can be assessed from the reservoir of prostate cancer in autopsy studies that report incidental prostate cancer rates in men who died of other causes. We aimed to estimate the age-specific incidental cancer prevalence from all published autopsy studies. We identified eligible studies by searches of Medline and Embase, forward and backward citation searches and contacting authors. We screened the titles and abstracts of all articles; checked the full-text articles for eligibility and extracted clinical and pathology data using standardized forms. We extracted mean cancer prevalence, age-specific cancer prevalence and validity measures and then pooled data from all studies using logistic regression models with random effects. The 29 studies included in the review dated from 1948 to 2013. Incidental cancer was detected in all populations, with no obvious time trends in prevalence. Prostate cancer prevalence increased with each decade of age, OR = 1.7 (1.6-1.8), and was higher in studies that used the Gleason score, OR = 2.0 (1.1-3.7). No other factors were significantly predictive. The estimated mean cancer prevalence increased in a nonlinear fashion from 5% (95% CI: 3-8%) at age <30 years to 59% (95% CI: 48-71%) by age >79 years. There was substantial variation between populations in estimated cancer prevalence. There is a substantial reservoir of incidental prostate cancer which increases with age. The high risk of overdiagnosis limits the usefulness of prostate cancer screening.
authors.affiliation: Centre for Research in Evidence Based Practice (CREBP), Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Qld, Australia.|Screening and Diagnostic Test Evaluation Program (STEP), School of Public Health, University of Sydney.
authors.forename: Katy J L
authors.initials: KJ
authors.lastname: Bell
authors.affiliation: Centre for Research in Evidence Based Practice (CREBP), Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Qld, Australia.
authors.forename: Chris
authors.initials: C
authors.lastname: Del Mar
authors.affiliation: Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Qld, Australia.
authors.forename: Gordon
authors.initials: G
authors.lastname: Wright
authors.affiliation: Department of Family Medicine, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.|Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.
authors.forename: James
authors.initials: J
authors.lastname: Dickinson
authors.affiliation: Centre for Research in Evidence Based Practice (CREBP), Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Qld, Australia.
authors.forename: Paul
authors.initials: P
authors.lastname: Glasziou
mesh_terms: D000367:Age Factors; D001344:Autopsy / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D015995:Prevalence; D011471:Prostatic Neoplasms / Q000453:epidemiology*
keywords: autopsy; early detection of cancer; mass screening; prostatic neoplasms
references.citation: J Natl Cancer Inst. 1973 May;50(5):1137-44
references.pmid: 4712588
references.citation: Med J Islam Repub Iran. 2012 May;26(2):73-7
references.pmid: 23483598
references.citation: J Natl Cancer Inst. 2007 Oct 3;99(19):1484-9
references.pmid: 17895474
references.citation: J Natl Cancer Inst. 1980 Aug;65(2):311-6
references.pmid: 6931251
references.citation: Ir J Med Sci. 2010 Mar;179(1):43-9
references.pmid: 19562407
references.citation: J Clin Pathol. 1949 Aug;2(3):197-208
references.pmid: 16810853
references.citation: Can J Urol. 2014 Oct;21(5):7496-506
references.pmid: 25347377
references.citation: Cancer. 1953 May;6(3):531-54
references.pmid: 13042777
references.citation: JAMA. 2011 Dec 28;306(24):2721-2
references.pmid: 22203543
references.citation: J Urol. 2010 May;183(5):1792-6
references.pmid: 20299055
references.citation: Scand J Urol Nephrol. 1968;2(2):65-71
references.pmid: 4185315
references.citation: J Urol. 2004 Oct;172(4 Pt 1):1297-301
references.pmid: 15371827
references.citation: J Natl Cancer Inst. 2010 May 5;102(9):605-13
references.pmid: 20413742
references.citation: Histopathology. 2014 Feb;64(3):405-11
references.pmid: 24102975
references.citation: BMJ. 2012;344:e3502
references.pmid: 22645185
references.citation: J Clin Epidemiol. 2008 Jan;61(1):41-51
references.pmid: 18083461
references.citation: Prostate. 2006 Sep 1;66(12):1319-28
references.pmid: 16688747
references.citation: Schweiz Med Wochenschr. 1948 May 22;78(20):473-5
references.pmid: 18868526
references.citation: Int J Cancer. 2011 Oct 15;129(8):1881-8
references.pmid: 21154740
references.citation: Lancet. 2014 Dec 6;384(9959):2027-35
references.pmid: 25108889
references.citation: Tohoku J Exp Med. 1961 Aug 25;74:265-85
references.pmid: 14454090
references.citation: Scand J Urol Nephrol. 1970;4(2):93-7
references.pmid: 5518094
references.citation: J Urol. 1993 Aug;150(2 Pt 1):379-85
references.pmid: 8326560
references.citation: Cancer. 2007 May 1;109(9):1877-86
references.pmid: 17372918
references.citation: Int J Cancer. 1977 Nov 15;20(5):680-8
references.pmid: 924691
references.citation: Nat Rev Cancer. 2014 Apr;14(4):209-10
references.pmid: 25688403
references.citation: Acta Pathol Microbiol Scand A. 1973 Mar;81(2):148-58
references.pmid: 4120992
references.citation: Scand J Urol Nephrol. 1980;14(1):29-35
references.pmid: 6154966
references.citation: Ann Intern Med. 1997 Mar 15;126(6):468-79
references.pmid: 9072935
references.citation: Eur Urol. 2005 Nov;48(5):739-44
references.pmid: 16203079
references.citation: Acta Pathol Microbiol Scand. 1958;44(1):64-7
references.pmid: 13594464
references.citation: J Natl Cancer Inst. 2013 Jul 17;105(14):1050-8
references.pmid: 23847245
references.citation: Virchows Arch. 2014 May;464(5):583-7
references.pmid: 24590584
references.citation: Prostate. 1996 May;28(5):295-9
references.pmid: 8610055
references.citation: Prostate. 2003 Feb 15;54(3):238-47
references.pmid: 12518329
references.citation: Eur J Cancer Prev. 2010 Nov;19(6):413-6
references.pmid: 20679895
references.citation: J Natl Cancer Inst. 1988 Jul 6;80(9):683-7
references.pmid: 3373558
references.citation: Ann R Coll Surg Engl. 1954 Oct;15(4):236-49
references.pmid: 13208101